Sat.Jan 01, 2022 - Fri.Jan 07, 2022

10 clinical trials to watch in the first half of 2022

Bio Pharma Dive

Biotech stocks ended 2021 in a slump. But positive results from eagerly anticipated studies in breast cancer, schizophrenia and Alzheimer's disease could help turn the sector's fortunes around

The financial toxicity of treating cancer

World of DTC Marketing

(Stat News) Today, a study followed 380 patients being treated at community oncology groups across the U.S. after they were diagnosed with metastatic colon cancer. They told the researchers that insurance didn’t protect them from serious money problems.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Finally: A comprehensive diagnostic guide to a well-established boxwood disease

Scienmag

For more than 150 years, Volutella blight has been one of the most common diseases of the loved and iconic boxwood plant as well as other plants in the family, including pachysandra and sarcococca. Despite its presence on every continent except Antarctica, the disease can be hard to identify.

Revised PhRMA Code Took Effect on January 1, 2022, and Certain State Obligations Follow

FDA Law Blog

By Faraz Siddiqui — Happy New Year! On January 1, 2022, the recently revised version of the PhRMA Code on Interactions with Health Care Professionals went into effect. We summarized the major revisions to the Code in a blog post when it was released in August 2021.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Pfizer, BioNTech bet mRNA can make a better shingles vaccine

Bio Pharma Dive

The pharma company, already partnered with BioNTech on vaccines for COVID-19 and influenza, will pay $225 million upfront to further expand its work with the German biotech

A realistic view of healthcare in 2022

World of DTC Marketing

Yes, there will be changes in healthcare in the coming years but put away the thoughts that telehealth and wearable devices will revolutionize healthcare. More and more patients demand a level of service they want with the increased costs of health insurance premiums.

More Trending

AI providing the edge against cancer?

Pharma Phorum

The global R&D pipeline is dominated by potential treatments in oncology and this is also where the investment is flowing.

As three biotechs head to Wall Street, a battered sector braces for a pullback

Bio Pharma Dive

Amylyx, CinCor and Vigil raised about $480 million combined, a sign of continued investor interest in biotech IPOs. But industry analysts expect fewer and smaller offerings in 2022 due to investor fatigue from high valuations

263
263

The disdain of big pharma

World of DTC Marketing

Drug companies raised the prices on hundreds of medications on Jan. 1, with most prices up 5% to 6% on average.

Accidental tree wound reveals novel symbiotic behavior

Scienmag

One afternoon, during the early days of the COVID-19 pandemic in Panama, a bored teenager with a slingshot and a clay ball accidentally shot entry and exit holes in a Cecropia tree trunk.

81

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

BioTech 365

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Charles River Laboratories to Present at J.P. Morgan Healthcare Conference WILMINGTON, Mass.–(BUSINESS –(BUSINESS WIRE)–$CRL #CRL–Charles River Laboratories International, Inc.

77

Biogen brings in a successor to Spinraza

Bio Pharma Dive

The company spent $60 million to secure global rights to an experimental drug developed by Ionis Pharmaceuticals to treat spinal muscular atrophy

Drugs 251

The most significant threat to American healthcare

World of DTC Marketing

The estimated numbe r of annual deaths attributable to obesity among U.S. adults is approximately 280,000 based on H.R.s from all subjects and 325,000 based on H.R.s from only nonsmokers and never-smokers. As the N.Y.

Simple pH adjustment may enable a preventative Covid-19 nasal and throat spray

Scienmag

Mechanical engineering and materials science professor David Needham has shown that a slight increase in solution pH might be all it takes to turn a metabolic inhibiting drug, traditionally used to treat gut parasites, into a promising prophylactic/preventative nasal spray and early treatment throat spray for COVID-19.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Covid Treatments Including Paxlovid Are Rationed as Cases Spike

NY Times

Scarce supplies and surging Covid cases have caused health officials, hospitals, doctors and patients to scramble for pills and infusions.

Lilly pours more money into genetic treatments for neurological diseases

Bio Pharma Dive

For $50 million, Lilly has secured rights to a technology that's meant to transport nucleic acid therapies in a way that's more targeted and better tolerated than other methods

Good Rx? Actually not

World of DTC Marketing

GoodRx promotes itself as a company that allows you to compare drug prices and find coupons at over 60,000 pharmacies across the country, but actually, most pharmacists hate it. When they say compare prescription drug prices, they mean the cost of a prescription if you aren’t using insurance.

Researchers develop first fully 3D-printed, flexible OLED display

Scienmag

MINNEAPOLIS / ST. PAUL (01/07/2022) — In a groundbreaking new study, researchers at the University of Minnesota Twin Cities used a customized printer to fully 3D print a flexible organic light-emitting diode (OLED) display.

New blood test can identify presence of cancer

Pharma Times

The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented

105
105

Avrobio stops work on rare disease gene therapy after unexpected study results

Bio Pharma Dive

The biotech's treatment was one of the furthest along in testing for Fabry, a rare inherited disease that's become a target for gene therapy developers

Gritstone bio trumpets first data for ‘multivariant’ COVID jab

Pharma Phorum

A COVID-19 vaccine that could work against multiple variants of the coronavirus – developed by US biotech Gritstone bio – has generated encouraging immune response data in its first clinical trial.

National Science Foundation and CASIS unveil seventh transport phenomena and nanoscale interactions solicitation to leverage space station

Scienmag

For seven consecutive years, the U.S. National Science Foundation (NSF) has collaborated with the Center for the Advancement of Science in Space, Inc.

Revised PhRMA Code Took Effect on January 1, 2022, and Certain State Obligations Follow

FDA Law Blog

By Faraz Siddiqui — Happy New Year! On January 1, 2022, the recently revised version of the PhRMA Code on Interactions with Health Care Professionals went into effect. We summarized the major revisions to the Code in a blog post when it was released in August 2021. Many of the updates relate to drug manufacturer practices with regard to speaker events, including meals, choice of venue, and attendance.

AstraZeneca adds to rare disease drug pipeline with Neurimmune deal

Bio Pharma Dive

Neurimmune, which will license to AstraZeneca an early-stage treatment for a rare form of cardiomyopathy, is probably best known for its invention of the antibody that became Biogen's Alzheimer's drug Aduhelm

Merck backs startup bringing AI to fertility treatment

Pharma Phorum

It’s no secret that fertility treatment is expensive and has a low success rate, placing a big financial and emotional burden on would-be parents. Now, a Canadian startup aims to tackle that problem though the use of artificial intelligence.

Study finds later school start times prevent sleep deprivation for parents of middle and high school students

Scienmag

A new study by researchers at National Jewish Health finds that parents of adolescents got more sleep when middle and high schools start about an hour later, while the sleep habits of parents of younger children were unaffected by earlier elementary school start times.

Biogen and Eisai move forward with investigational Alzheimer's therapy

BioPharma Reporter

Lecanemab, an investigational anti-amyloid beta (AÎ) protofibril antibody for the treatment of early Alzheimer's disease, has been granted Fast Track designation by the US Food and Drug Administration (FDA). Markets & Regulations

5 FDA approval decisions to watch in the first quarter

Bio Pharma Dive

The first three months of 2022 could bring clearances for a new type of immunotherapy and a first-of-its kind HIV drug as well as mark the start of a price battle in oncology

Digital health innovation in 2022: Anticipating healthcare trends ahead of the J.P. Morgan week

Pharma Phorum

We spoke with Tanja Dowe, ahead of the annual J.P.

The toilet of a First Temple period luxury villa reveals: Due to poor sanitary conditions, the Jerusalem elite suffered from infectious disease

Scienmag

A joint Tel Aviv University and the Israel Antiquities Authority study Credit: Ya’akov Billig, The Israel Antiquities Authority.

Shingles is new focus for Pfizer and BioNTech in mRNA vaccine development partnership

BioPharma Reporter

Pfizer and BioNTech, in what will be the third mRNA vaccine collaboration between the two companies, are teaming up on the development of a potential first mRNA-based vaccine for the prevention of shingles. Bio Developments

Sanofi cuts ties with Sangamo, sharpening focus on 'off-the-shelf' cell therapy

Bio Pharma Dive

The French pharma cited a "change in strategic direction" for ending a long-running pact focused on genetic medicines for blood diseases, led by a sickle cell treatment in early testing

FDA gives AbbVie’s c-Met lung cancer ADC a breakthrough tag

Pharma Phorum

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status.

Gravitational action of Sun and Moon influences behavior of animals and plants, study shows

Scienmag

The rhythms of activity in all biological organisms, both plants and animals, are closely linked to the gravitational tides created by the orbital mechanics of the Sun-Earth-Moon system.